SCHEMBL30284972

SCHEMBL30284972

NCCCC[C@H](N)C(=O)NCC(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)O

nearest known ligand 0.49

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ OPRM1 P35372 4/20 0.49
▸ F2 P00734 3/20 0.44
▸ NTMT1 Q9BV86 1/20 0.44
▸ OPRD1 P41143 3/20 0.43
▸ MEN1 O00255 1/20 0.43
▸ TP53 P04637 1/20 0.43
▸ CYP1A2 P05177 1/20 0.43
▸ CYP2D6 P10635 1/20 0.43
▸ MAPT P10636 1/20 0.43
▸ CYP2C9 P11712 1/20 0.43
▸ CYP2C19 P33261 1/20 0.43
▸ KMT2A Q03164 1/20 0.43
▸ APLNR P35414 1/20 0.42
▸ DPP4 P27487 1/20 0.40
▸ FAP Q12884 1/20 0.40
▸ DPP8 Q6V1X1 1/20 0.40
▸ DPP9 Q86TI2 1/20 0.40
▸ DPP7 Q9UHL4 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30781984 0.89 OPRM1 (0.43) OPRM1OPRD1KMT2ADPP4FAP
SCHEMBL30297051 0.88 APLNR (0.47) OPRM1OPRD1APLNR
SCHEMBL30431697 0.86 F2 (0.45) F2NTMT1MEN1TP53CYP1A2
SCHEMBL29423417 0.86 APLNR (0.45) OPRM1NTMT1OPRD1APLNR
SCHEMBL29752677 0.86 OPRM1 (0.60) OPRM1F2DPP4FAPDPP8
SCHEMBL31661806 0.85 APLNR (0.47) OPRM1F2NTMT1APLNR
SCHEMBL10396256 0.84 MEN1 (0.49) MEN1TP53CYP1A2CYP2D6MAPT
SCHEMBL29666108 0.84 APLNR (0.47) OPRD1MEN1TP53CYP1A2CYP2D6
SCHEMBL29569081 0.83 F2 (0.47) OPRM1F2NTMT1OPRD1APLNR
SCHEMBL30918789 0.83 OPRM1 (0.46) OPRM1F2NTMT1OPRD1APLNR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-109476732-B Trispecific and/or trivalent binding proteins 赛诺菲 2024-03-22 — — CN disclosed
CN-117069855-A Trispecific and/or trivalent binding proteins for the prevention or treatment of HIV infection 赛诺菲 2023-11-17 — — CN disclosed
CN-116789841-A Trispecific and/or trivalent binding proteins for the prevention or treatment of HIV infection 赛诺菲 2023-09-22 — — CN disclosed
CN-116675776-A Trispecific and/or trivalent binding proteins for the prevention or treatment of HIV infection 赛诺菲 2023-09-01 — — CN disclosed
CN-109311966-B Trispecific and/or trivalent binding proteins for use in the prevention or treatment of HIV infection 赛诺菲 2023-03-10 — — CN disclosed
Send feedback